Pacemaker

Cardiac Pacemaker: The Precision Regulation Logic of Heart Rhythm and Recommendations for Authoritative Hospitals

The normal beating of the heart relies on its own electrical conduction system, similar to a “natural pacemaker” of a precision instrument. When this system malfunctions due to aging, diseases (such as coronary artery disease, cardiomyopathy), congenital defects, or other factors, leading to bradycardia, atrioventricular block, or other issues, an artificial cardiac pacemaker becomes a key medical device to save lives and improve quality of life. With “extracorporeal implantation and precise energy supplementation” as its core logic, it drives the heart to beat regularly by simulating the heart’s natural electrical signals, and has become one of the most widely used treatment methods for arrhythmia globally. Understanding its working logic and selecting an authoritative medical institution are the core prerequisites for ensuring treatment outcomes.

I. Core Logic Analysis of Cardiac Pacemakers

The essence of a cardiac pacemaker is an “artificial electrical signal generator,” and its logical system revolves around “identifying abnormal rhythms, precise energy-supplemented pacing, and adapting to patient needs,” covering the entire process of preoperative evaluation, type selection, implantation operation, and postoperative management.

(I) Treatment Decision-Making Logic: Why Is Pacemaker Implantation Needed?

The decision to implant a pacemaker follows the principle of “abnormal rhythm + symptom correlation,” focusing on diseases related to “cardiac electrical conduction disorders”:

• Pacemaker implantation is the first-choice treatment when patients present with severe sinus bradycardia (resting heart rate beats per minute), second-degree or higher atrioventricular block, sinoatrial block, or experience amaurosis fugax, syncope, dizziness, fatigue, or significantly decreased exercise tolerance due to arrhythmia. This is because impaired cardiac electrical conduction leads to insufficient cardiac output, resulting in ischemia and hypoxia of the brain and other organs throughout the body. In severe cases, it can cause Adams-Stokes syndrome or even sudden death. Drug therapy has limited efficacy and obvious side effects, and cannot replace the “active pacing” function of a pacemaker.
• From the perspective of risk-benefit ratio, the perioperative complication rate of pacemaker implantation is only 1%-3%. The recurrence rate of syncope in patients after surgery can be reduced by more than 90%, and the 5-year survival rate is significantly improved. Especially for elderly patients, it can effectively restore normal living abilities and reduce the risk of accidents caused by bradycardia.

(II) Type Selection Logic of Pacemakers: Adapting to Different Patient Needs

The selection of pacemaker type requires precise matching based on “arrhythmia type, cardiac function status, patient age, and lifestyle needs,” with four core categories:

1. Single-Chamber Pacemaker: Core logic is “single-site pacing”—only one electrode lead is implanted in the right atrium or right ventricle, suitable for patients with simple sinus bradycardia or atrioventricular block. Its advantages include simple structure, minimal implantation trauma, long battery life (usually 8-10 years), and high cost-effectiveness, making it suitable for elderly patients with multiple underlying diseases.
2. Dual-Chamber Pacemaker: Core logic is “simulating physiological rhythm”—one electrode lead is implanted in both the right atrium and right ventricle. It triggers ventricular pacing after sensing atrial electrical signals, achieving synchronized contraction of the “atrium-ventricle,” which is closer to the natural heart rhythm. Suitable for patients with atrioventricular block combined with sinus bradycardia, or those with high requirements for cardiac synchronization (such as young and middle-aged people with good cardiac function), it can reduce the risk of pacemaker syndrome (e.g., dizziness, chest tightness, fatigue).
3. Triple-Chamber Pacemaker (Cardiac Resynchronization Therapy, CRT): Core logic is “correcting ventricular asynchrony”—electrode leads are implanted in the right atrium, right ventricle, and left ventricle respectively, suitable for patients with heart failure combined with ventricular conduction delay (e.g., left bundle branch block). Such patients have decreased cardiac pumping efficiency due to asynchronous contraction of the left and right ventricles. CRT can improve coordinated ventricular contraction through synchronized pacing, enhance cardiac function, and reduce the rate of heart failure readmission and mortality.
4. Implantable Cardioverter-Defibrillator (ICD): Core logic is “dual protection of pacing + defibrillation”—it has both pacemaker functions and shock defibrillation functions, suitable for patients at risk of malignant arrhythmia (e.g., those who have experienced cardiac arrest, severe ventricular tachycardia, or cardiomyopathy with high risk factors for sudden death). When the device detects life-threatening arrhythmia, it can automatically deliver an electric shock for defibrillation to save the patient’s life, while providing pacing support when bradycardia occurs.

(III) Pacemaker Implantation and Postoperative Management Logic

1. Implementation Logic of Implantation Surgery

• Preoperative Evaluation Logic: Electrocardiogram and Holter monitoring are used to clarify the type and severity of arrhythmia; echocardiography assesses cardiac function, ventricular size, and structure; blood tests (liver and kidney function, coagulation function) rule out surgical contraindications. Meanwhile, the pacemaker type and electrode implantation route (usually subclavian vein or cephalic vein) are selected based on the patient’s condition.
• Surgical Operation Logic: The surgery is performed under local anesthesia, and the patient remains awake throughout. The doctor makes a 2-3 cm incision in the left or right chest (below the collarbone), separates the subcutaneous tissue to create a pocket, delivers the electrode lead to the target cardiac site (atrium or ventricle) through a vein, confirms the electrode position via X-ray fluoroscopy, and tests pacing parameters (pacing threshold, sensing sensitivity). Subsequently, the pacemaker pulse generator (battery and circuit part) is implanted into the pocket and the incision is sutured. The entire surgery takes about 1-2 hours, with minimal trauma and bleeding.
• Immediate Postoperative Management Logic: After surgery, the patient is transferred to the intensive care unit for 24-hour monitoring to observe pacing signals, heart rate, and incision conditions, preventing electrode displacement; antibiotics are routinely used for 24-48 hours to prevent infection; patients can get out of bed 1-2 days after surgery, avoiding strenuous exercise and excessive stretching of the operative limb.

2. Long-Term Postoperative Management Logic: Ensuring Long-Term Effective Operation of the Pacemaker

• Device Monitoring Logic: Regular follow-up is required after pacemaker implantation, focusing on “monitoring battery life and pacing parameters”—follow-up visits are conducted at 1 month, 3 months, and 6 months after surgery, then annually. When the battery is nearly exhausted (usually about 1 year remaining), the follow-up interval needs to be shortened. Specialized equipment is used to read internal pacemaker data, adjust parameters such as pacing frequency and sensing sensitivity to ensure the device matches the patient’s cardiac status, and evaluate the remaining battery power to arrange replacement surgery in a timely manner.
• Lifestyle Management Logic: Avoid strenuous exercise (e.g., weightlifting, playing ball) with the operative limb to prevent electrode lead fracture; stay away from strong magnetic field environments (e.g., large MRI equipment, high-voltage substations, industrial electromagnetic equipment), but daily household appliances (mobile phones, computers, microwave ovens) will not affect device operation (it is recommended to keep mobile phones at least 15 cm away from the pacemaker and avoid placing them in the chest pocket); avoid chest impact, protect the pocket area, and prevent infection or device displacement.
• Complication Prevention Logic: Long-term observation of the incision for signs of infection such as redness, exudation, or pain; seek medical attention promptly if fever or local inflammation occurs; be alert to complications such as electrode displacement (manifested as dizziness, palpitations, disappearance of pacing signals), lead fracture, or pocket hematoma, and recheck immediately if abnormal symptoms appear; patients taking anticoagulants (e.g., combined with atrial fibrillation) need regular monitoring of coagulation function to avoid bleeding risks.

II. Recommendations for Authoritative Hospitals for Pacemaker Implantation in China

The core criteria for selecting authoritative hospitals for pacemaker implantation are “cardiology strength, pacing treatment experience, ability to handle complex cases, and complication control rate.” The following are top domestic institutions (data sources: 2022 Fudan Edition Hospital Rankings, official hospital disclosures):

1. Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences

• Core Advantages: National Center for Cardiovascular Diseases, a leader in pacing treatment in China, performing over 3,000 pacemaker implantations annually (including CRT and ICD accounting for more than 40%). The success rate of treating complex cases (e.g., heart failure combined with multiple organ dysfunction, congenital heart disease combined with atrioventricular block) exceeds 99%;
• Featured Technologies: Pioneered leadless pacemaker implantation, MRI-compatible pacemaker implantation, and His bundle pacing (closer to physiological conduction) in China, and is at the international advanced level in the field of cardiac resynchronization therapy combined with drug optimization;
• Address: No. 167 Beilishi Road, Xicheng District, Beijing.

2. Beijing Anzhen Hospital, Capital Medical University

• Core Advantages: Top cardiovascular specialist hospital in China, performing over 2,500 pacemaker implantations annually, with the number of ICD implantations ranking among the top in the country. The perioperative complication rate is it is a national training base for arrhythmia interventional therapy;
• Featured Technologies: Rich experience in the comprehensive treatment of malignant arrhythmia (ICD + radiofrequency ablation), optimized CRT treatment for heart failure patients, and minimally invasive pacemaker implantation for elderly high-risk patients;
• Address: No. 2 Anzhen Road, Chaoyang District, Beijing.

3. Zhongshan Hospital, Fudan University

• Core Advantages: One of the birthplaces of cardiology in China, with a long history of pacing treatment. It performs over 2,000 pacemaker implantations annually, with a success rate of 98% for complex pacing surgeries (e.g., cases with difficult left ventricular lead implantation) and a well-established postoperative follow-up system;
• Featured Technologies: Pioneered precise pacemaker implantation under three-dimensional mapping and clinical application of leadless pacemakers in China, and is at the domestic leading level in the treatment of pacemaker complications (e.g., lead fracture repair);
• Address: No. 180 Fenglin Road, Xuhui District, Shanghai.

4. West China Hospital, Sichuan University

• Core Advantages: Cardiovascular disease diagnosis and treatment center in Western China, performing over 1,500 pacemaker implantations annually, covering pacing treatment for adults and children, and specializing in pacing intervention for atrioventricular block after congenital heart disease surgery;
• Featured Technologies: Mature minimally invasive pacemaker implantation technology, with rich experience in long-term management of heart failure patients treated with CRT and rehabilitation guidance for patients after ICD implantation;
• Address: No. 37 Guoxue Lane, Wuhou District, Chengdu.

5. Guangdong Provincial People’s Hospital

• Core Advantages: Arrhythmia treatment center in South China, performing over 1,800 pacemaker implantations annually, with the number of CRT/ICD implantations ranking first in South China. It is at the domestic leading level in the comprehensive treatment of complex arrhythmia combined with heart failure;
• Featured Technologies: At the domestic advanced level in para-Hisian pacing, left ventricular quadripolar lead implantation, and removal and reimplantation of infected pacemakers, and has established a comprehensive remote pacing follow-up system;
• Address: No. 106 Zhongshan Second Road, Yuexiu District, Guangzhou.

III. Conclusion: Precise Adaptation and Scientific Management

The logical essence of a cardiac pacemaker is to “simulate the heart’s natural electrical signals and precisely regulate rhythm.” Its success relies on accurate preoperative evaluation, appropriate device selection, exquisite implantation operation, and long-term postoperative follow-up. For patients, early detection of heart rate abnormalities (e.g., electrocardiogram during regular physical examinations indicating bradycardia or atrioventricular block) and timely medical consultation are crucial for health protection. Professional doctors will determine whether pacemaker implantation is necessary.

With the advancement of medical technology, pacemakers have evolved from traditional single-chamber devices to leadless, MRI-compatible, intelligent devices with both therapeutic and defibrillation functions, providing safer and more physiologically suitable treatment options for patients with different needs. By strictly following medical advice and conducting device follow-up and lifestyle management after surgery, most patients can resume normal life, work, and even participate in moderate physical exercise, achieving high-quality survival.